Osiris Therapeutics (OSIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2007 | 09-2007 | 06-2007 | 03-2007 | 12-2006 | |
| Sales | 5,985 | 0 | 0 | 0 | 2,958 |
| Cost of Goods | 2,725 | N/A | N/A | N/A | 1,333 |
| Gross Profit | 3,260 | N/A | N/A | N/A | 1,625 |
| Operating Expenses | 22,313 | 11,842 | 11,646 | 9,721 | 14,489 |
| Operating Income | -15,968 | -11,842 | -11,646 | -9,721 | -11,959 |
| Interest Expense | 5,604 | 330 | 418 | 343 | 709 |
| Pre-tax Income | -21,572 | -12,172 | -12,064 | -10,064 | -12,668 |
| Net Income Continuous | -21,572 | -12,172 | -12,064 | -10,064 | -12,668 |
| Net Income Discontinuous | 1,986 | 1,782 | 1,606 | -1,437 | N/A |
| Net Income | $-21,572 | $-10,390 | $-10,458 | $-11,501 | $-12,668 |
| EPS Basic Total Ops | -0.73 | -0.36 | -0.37 | -0.42 | -0.46 |
| EPS Basic Continuous Ops | -0.73 | -0.42 | -0.43 | -0.37 | -0.46 |
| EPS Basic Discontinuous Ops | 0.07 | 0.06 | 0.06 | -0.05 | N/A |
| EPS Diluted Total Ops | -0.73 | -0.36 | -0.37 | -0.42 | -0.46 |
| EPS Diluted Continuous Ops | -0.73 | -0.42 | -0.43 | -0.37 | -0.46 |
| EPS Diluted Discontinuous Ops | 0.07 | 0.06 | 0.06 | -0.05 | N/A |
| EBITDA(a) | $-17,661 | $-11,402 | $-11,236 | $-9,310 | $-12,201 |